Furthermore, downregulated PD-1 expression may stimulate a positive feedback effect, promoting MS-related inflammatory responses via the interaction of its ligands (PDL1), although the expression of PD-1 is not sufficient to define the function of CD8+ T cells in the absence of its ligand. This evidence concerns the gene PDCD1 and myeloid sarcoma.